Tags: US | Earns | Merck

Schering-Plough Purchase Lifts Merck Sales, Profit

Tuesday, 16 Feb 2010 07:34 AM

Drugmaker Merck & Co. posts huge jumps in revenue and profit in the fourth quarter, mainly due to its purchase of longtime partner Schering-Plough Corp.

Merck says it made $6.49 billion as sales jumped to $10.09 billion, fueled by the addition of Schering-Plough's products and higher sales for Merck vaccines and some of its top-selling drugs. Those include asthma and allergy pill Singulair and blood pressure pills Cozaar and Hyzaar.

The Whitehouse Station, N.J., company is reporting earnings per share of $2.35.

The report is the first since Merck bought Schering-Plough in November for $41.1 billion, making the combined operation the world's second-biggest pharmaceutical company.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

1Like our page
2Share
Companies
Drugmaker Merck Co. posts huge jumps in revenue and profit in the fourth quarter, mainly due to its purchase of longtime partner Schering-Plough Corp.Merck says it made $6.49 billion as sales jumped to $10.09 billion, fueled by the addition of Schering-Plough's products...
US,Earns,Merck
105
2010-34-16
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved